Population
4 healthy male volunteers
Comparison
6-h i.v. infusions of TxB2 at 0.1, 1.0, and 5.0… vs 6-h i.v. infusion of vehicle alone
Design
Other, random order
Follow-up
up to 24 hours after infusions
Authors
Loading...
Plasma TxB2 assays likely overestimate endogenous levels via ex vivo activation; leaves open validity of prior thromboxane measurements in cardiovascular research.
This physiological study provides an estimate of endogenous thromboxane release and suggests that ex vivo platelet activation confounds estimates based on plasma TxB2.
Ciabattoni et al. (1986) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: